Bulk BPC 5 mg + TB 5 mg (10 Vials)

Bulk BPC 5 mg + TB 5 mg (10 Vials) — Lyophilized dual-peptide research material supplied as 10 individually sealed vials (each vial contains BPC 5 mg + TB 5 mg) with labeled CAS references; Research Use Only — not for human or veterinary use.

BPC-157 (preclinical / mechanistic research)

Reported in in-vitro and animal studies as being investigated for:

• Wound/tendon–ligament repair models and angiogenesis-related pathways (new vessel formation / perfusion recovery in injury models).

• Gastrointestinal mucosal protection/repair in various rodent models (often discussed as “stable gastric pentadecapeptide” literature).

• Inflammation/oxidative-stress signaling and NO-related pathways (reported mechanistic hypotheses across preclinical papers/reviews).

TB-500 (Ac-LKKTETQ; thymosin β4 fragment) (preclinical / mechanistic research)

TB-500 is described as an N-acetylated fragment derived from thymosin β4’s actin-binding region.
Reported research interest includes:

• Cytoskeletal / actin modulation and downstream effects on cell migration (common rationale for tissue-repair models).

• Investigation in wound repair / tissue remodeling and angiogenesis-related experimental contexts (largely preclinical).